Health Imaging July 26, 2024
The Centers for Medicare and Medicaid services has officially assigned a national payment rate to an artificial intelligence-assisted prostate cancer mapping tool.
Healthcare company Avenda Health made the announcement Thursday, noting that the payment assignment applies to the company’s Unfold AI tool. The American Medical Association also implemented a Category III code for reimbursement related to the use of the product.
The code, 0898T, will enable providers to bill for utilizing the prostate cancer estimation maps produced by the tool. These maps are derived from advanced analysis of image-guided fusion biopsy and pathology, and include tumor margin visualization, margin determination, and physician interpretation and reporting.
The Medicare reimbursement rate is determined by the Hospital Outpatient Prospective Payment...
Today's Sponsors
Today's Sponsor